Abstract:
A novel process and intermediates thereof for making 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones of the type shown below from appropriate phenyl hydrazines is described. These compounds are useful as factor Xa inhibitors.
Abstract:
The present invention pertains to bis(methanesulfonic acid), bis(ethanesulfonic acid), and camphoric acid salts of chemokine receptor inhibitor N-[2-({(3R)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohexyl]-pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)-benzamide, methods of preparing the same, and methods of using the same.
Abstract:
Techniques are disclosed to produce virtual views of a complex scene. The virtual views are substantially free from aliasing even when using a relatively sparse set of images of the scene. In a described implementation, a scene is split into one or more coherent layers. The boundaries of the coherent layers are propagated across a plurality of frames corresponding to the scene. The splitting may be further refined (e.g., in accordance with user feedback) to present a virtual view of the scene.
Abstract:
A novel process for making 1,3,5-trisubstituted pyrazoles of the type shown below from appropriate phenyl hydrazines is described. These compounds are useful as factor Xa inhibitors.
Abstract:
Processes for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piperazinyl)carbonyl]phenoxy]-4-oxo-l-azetidine carboxamide, a useful inhibitor of human leukocyte elastase (HLE), are described. The process including (a) contacting a compound of formula (II): with a compound of formula (III): in a first polar solvent system in the presence of an aqueous base and a phase transfer catalyst, to form the title compound, or a salt form thereof.
Abstract:
Processes for the preparation of R-.alpha.-propyl-piperonyl amine and its analogs, such compounds being useful intermediates in the preparation of elastase inhibitors, and intermediates useful for making R-.alpha.-propyl-piperonyl amine are described.
Abstract:
The present invention provides fused aryl and heteroaryl derivatives of Formula I: wherein X, V, Y, U, W, Z, R1, R2, Cy, and Ar are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
Abstract:
An LCD display design system and method are disclosed. The method includes performing operations by a variety of operation modules after initial parameters are input and an operation type is selected, so as to generate operation results and transfer the operation results to an integration module; integrating the operation results by an integration module to generate a correspondence relation such as an operation window, a compare-table or an equation, and further transferring the operation results and the correspondence relation to an output module such that the output module can display performance variations of a variety of designs corresponding to the different initial parameters. Therefore, the present invention provides a user with a convenient way to obtain optimal design parameters for designing a display pixel circuit.